Jpmorgan Chase & Co »

Regeneron Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $135M 1.2M 114.17
2010-12-31 $5.3M 154k 34.19

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals